Back to User profile » Dr Harm van Tinteren
Paper published by Dr Harm van Tinteren:
Review
First-line tyrosine kinase inhibitors in EGFR mutation-positive non-small-cell lung cancer: a network meta-analysis
Holleman MS, van Tinteren H, Groen HJM, Al MJ, Uyl-de Groot CA
OncoTargets and Therapy 2019, 12:1413-1421
Published Date: 20 February 2019